메뉴 건너뛰기




Volumn 20, Issue 3, 2006, Pages 313-317

The clinical impact of 1:1 conversion from Neoral to a generic cyclosporine (Gengraf) in renal transplant recipients with stable graft function

Author keywords

Bioequivalence; Cyclosporine; Kidney transplant

Indexed keywords

CREATININE; CYCLOSPORIN A;

EID: 33745077432     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2005.00483.x     Document Type: Article
Times cited : (34)

References (15)
  • 1
    • 0033155216 scopus 로고    scopus 로고
    • Renal transplantation, past, present and future
    • Ponticelli C, Tarantino A, Vegeto A. Renal transplantation, past, present and future. J Nephrol 1999: 12(Suppl. 2): S105.
    • (1999) J Nephrol , Issue.12 SUPPL. 2
    • Ponticelli, C.1    Tarantino, A.2    Vegeto, A.3
  • 2
    • 0027988313 scopus 로고
    • Cyclosporine pharmacokinetics and variability from a microemulsion formulation - A multicenter investigation in kidney transplant patients
    • Kovarik JM, Mueller EA, van Bree JB et al. Cyclosporine pharmacokinetics and variability from a microemulsion formulation - a multicenter investigation in kidney transplant patients. Transplantation 1994: 58: 658.
    • (1994) Transplantation , vol.58 , pp. 658
    • Kovarik, J.M.1    Mueller, E.A.2    van Bree, J.B.3
  • 3
    • 7144259774 scopus 로고    scopus 로고
    • Randomized, double blind, one-year study of the safety and tolerability of cyclosporine microemulsion compared with conventional cyclosporine in renal transplant patients
    • International Sandimmun Neoral Study Group
    • Frei UA, Neumayer HH, Buchholz B, Niese D, Mueller EA. Randomized, double blind, one-year study of the safety and tolerability of cyclosporine microemulsion compared with conventional cyclosporine in renal transplant patients. International Sandimmun Neoral Study Group. Transplantation 1998: 65: 1455.
    • (1998) Transplantation , vol.65 , pp. 1455
    • Frei, U.A.1    Neumayer, H.H.2    Buchholz, B.3    Niese, D.4    Mueller, E.A.5
  • 4
    • 0028952478 scopus 로고
    • Reduced inter- and intra-subject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals
    • K ahan BD, D unn J, F itts C et al. Reduced inter- and intra-subject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals. Transplantation 1995: 59: 505.
    • (1995) Transplantation , vol.59 , pp. 505
    • Kahan, B.D.1    Dunn, J.2    Fitts, C.3
  • 5
    • 1642391660 scopus 로고    scopus 로고
    • Long-term kidney transplant outcomes in patients receiving oil-based or microemulsion formulations of cyclosporine
    • Medina-Pestana JO, Felipe CR, Park SI et al. Long-term kidney transplant outcomes in patients receiving oil-based or microemulsion formulations of cyclosporine. Transplant Proc 2004: 36: 74S.
    • (2004) Transplant Proc , vol.36
    • Medina-Pestana, J.O.1    Felipe, C.R.2    Park, S.I.3
  • 6
    • 0020619251 scopus 로고
    • A randomized clinical trial of cyclosporine in cadaveric renal transplantation
    • A nonymous
    • A nonymous. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. N Engl J Med 1983: 309: 809.
    • (1983) N Engl J Med , vol.309 , pp. 809
  • 7
    • 0037108716 scopus 로고    scopus 로고
    • Conversion of stable renal allograft recipients to a bioequivalent cyclosporine formulation
    • R oza A, T omlanovich S, M erion R et al. Conversion of stable renal allograft recipients to a bioequivalent cyclosporine formulation. Transplantation 2002: 74: 1013.
    • (2002) Transplantation , vol.74 , pp. 1013
    • Roza, A.1    Tomlanovich, S.2    Merion, R.3
  • 8
    • 0027537097 scopus 로고
    • On the intraindividual variability and chronobiology of cyclosporine pharmacokinetics in renal transplantation
    • Ohlman S, Lindholm A, Hagglund H, Sawe J, Kahan BD. On the intraindividual variability and chronobiology of cyclosporine pharmacokinetics in renal transplantation. Eur J Clin Pharmacol 1993: 44: 265.
    • (1993) Eur J Clin Pharmacol , vol.44 , pp. 265
    • Ohlman, S.1    Lindholm, A.2    Hagglund, H.3    Sawe, J.4    Kahan, B.D.5
  • 9
    • 0345104291 scopus 로고    scopus 로고
    • Circadian changes in pharmacokinetics of cyclosporin in healthy volunteers
    • Choi JS, Park HJ. Circadian changes in pharmacokinetics of cyclosporin in healthy volunteers. Res Commun Mol Pathol Pharmacol 1999: 103: 109.
    • (1999) Res Commun Mol Pathol Pharmacol , vol.103 , pp. 109
    • Choi, J.S.1    Park, H.J.2
  • 10
    • 0038798412 scopus 로고    scopus 로고
    • Neoral-to-Gengraf conversion in renal transplant recipients
    • Carnahan W, Cooper TY. Neoral-to-Gengraf conversion in renal transplant recipients. Transplant Proc 2003: 35: 1308.
    • (2003) Transplant Proc , vol.35 , pp. 1308
    • Carnahan, W.1    Cooper, T.Y.2
  • 11
    • 0043072348 scopus 로고    scopus 로고
    • Report of the American Society of Transplantation conference on immunosuppressive drugs and the use of generic immunosuppressants
    • Alloway RR, Isaacs R, Lake K et al. Report of the American Society of Transplantation conference on immunosuppressive drugs and the use of generic immunosuppressants. Am J Transplant 2003: 3: 1211.
    • (2003) Am J Transplant , vol.3 , pp. 1211
    • Alloway, R.R.1    Isaacs, R.2    Lake, K.3
  • 12
    • 0038045086 scopus 로고    scopus 로고
    • Transplantation, consent: A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin A. Berlin, Germany, November 19, 2001
    • Pollard S, Nashan B, Johnston A et al. Transplantation, consent: A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin A. Berlin, Germany, November 19, 2001. Clin Ther 2003: 25: 1654.
    • (2003) Clin Ther , vol.25 , pp. 1654
    • Pollard, S.1    Nashan, B.2    Johnston, A.3
  • 13
    • 33745088395 scopus 로고    scopus 로고
    • The potential impact of switching between various formulations of cyclosporine
    • Canadian Society of Transplantation Consensus papers
    • R oss H, W est L, K eown P, L evy G. The potential impact of switching between various formulations of cyclosporine. Canadian Society of Transplantation Consensus papers http://transplant.medical.org/ Critical_Dose_Drugs_Transplant.pdf
    • Ross, H.1    West, L.2    Keown, P.3    Levy, G.4
  • 14
    • 1642397422 scopus 로고    scopus 로고
    • Bioequivalence between cyclosporine microemulsion formulations may not translate into equivalent clinical outcomes
    • (Abstract 1211). Presented at the American Transplant Congress, May 2003
    • T aber T, B aillie G, A shcraft E et al. Bioequivalence between cyclosporine microemulsion formulations may not translate into equivalent clinical outcomes. Am J Transplant 2003: S5: 462. (Abstract 1211). Presented at the American Transplant Congress, May 2003.
    • (2003) Am J Transplant , vol.S5 , pp. 462
    • Taber, T.1    Baillie, G.2    Ashcraft, E.3
  • 15
    • 33745095954 scopus 로고    scopus 로고
    • Colloborative Transplant Study Newsletter 1: March Available at
    • Colloborative Transplant Study Newsletter 1: March 2001. Available at http://www.ctstransplant.org/public/literature/newsletters/2001/gif/ 2001-1.html
    • (2001)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.